Johnson & Johnson

Investor's Business Daily

Johnson & Johnson (JNJ) is stopping sales of its laparoscopic power morcellators, devices used to remove growths in the uterus, a week after the FDA warned that electronic surgical tools can spread cancer to other parts of the body. Shares rose 0.3% to 101.29.


View Comments (1)